# Retrospective Chart Review of Valstar

> **NCT01304173** · — · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 113 (actual)

## Conditions studied

- Carcinoma in Situ of Bladder

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01304173
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-09
- **Final completion:** 2011-10
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2014-02-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01304173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01304173, "Retrospective Chart Review of Valstar". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01304173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*